Aytu Biopharma, Inc
AYTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385818
No open-market purchases or sales by Aytu Biopharma, Inc insiders were filed in the last 90 days; 38 institutions reported holding it in 13F filings for Q2 2026, worth $8.25M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Aytu Biopharma, Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- −1 vs. Q4 2021
- Shares held
- 5.58M
- +1.76M (+46.0%) vs. Q4 2021
- Total value
- $6.02M
- +$927.0K (+18.2%) vs. Q4 2021
- New holders
- 7
- 9 more added
- Sold out
- 8
- 13 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AYTU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 38 | $8.25M |
| Q1 2026 | 37 | $10.7M |
| Q4 2025 | 39 | $9.81M |
| Q3 2025 | 33 | $6.73M |
| Q2 2025 | 32 | $7.45M |
| Q1 2025 | 31 | $2.49M |
| Q4 2024 | 29 | $3.19M |
| Q3 2024 | 24 | $4.81M |
| Q2 2024 | 27 | $5.99M |
| Q1 2024 | 27 | $5.46M |
| Q4 2023 | 22 | $5.02M |
| Q3 2023 | 22 | $4.65M |
| Q2 2023 | 21 | $2.73M |
| Q1 2023 | 21 | $1.21M |
| Q4 2022 | 42 | $1.52M |
| Q3 2022 | 53 | $1.64M |
| Q2 2022 | 41 | $2.50M |
| Q1 2022 | 44 | $6.02M |
| Q4 2021 | 46 | $5.10M |
| Q3 2021 | 49 | $12.2M |
| Q2 2021 | 61 | $26.0M |
| Q1 2021 | 72 | $48.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Aytu Biopharma, Inc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 2,379,936 | $2.57M | 0.07% | +2,379,936 | New |
| Renaissance Technologies LLC | 765,469 | $827.0K | 0.00% | +100,400+15.1% | Added |
| Vanguard Group Inc | 722,563 | $780.0K | 0.00% | −221,082−23.4% | Reduced |
| BlackRock Inc. | 545,907 | $589.0K | 0.00% | −2,817−0.5% | Reduced |
| Millennium Management LLC | 265,917 | $287.0K | 0.00% | −29,862−10.1% | Reduced |
| Geode Capital Management, LLC | 259,047 | $279.0K | 0.00% | +1,614+0.6% | Added |
| Commonwealth Equity Services, LLC | 109,785 | $118.0K | 0.00% | +1,999+1.9% | Added |
| State Street Corp | 97,684 | $105.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 57,380 | $62.0K | 0.00% | +25,352+79.2% | Added |
| D. E. Shaw & Co., Inc. | 56,329 | $61.0K | 0.00% | −53,309−48.6% | Reduced |
| Susquehanna Fundamental Investments, LLC | 53,530 | $58.0K | 0.00% | −18,095−25.3% | Reduced |
| Morgan Stanley | 51,218 | $56.0K | 0.00% | −138,924−73.1% | Reduced |
| Goldman Sachs Group Inc | 50,146 | $54.0K | 0.00% | +9,279+22.7% | Added |
| Northern Trust Corp | 48,632 | $53.0K | 0.00% | −211−0.4% | Reduced |
| Tower Research Capital LLC (TRC) | 27,423 | $30.0K | 0.00% | −1,693−5.8% | Reduced |
| Two Sigma Advisers, LP | 23,700 | $26.0K | 0.00% | +6,270+36.0% | Added |
| Schonfeld Strategic Advisors LLC | 16,900 | $18.0K | 0.00% | −100−0.6% | Reduced |
| Hunter Associates Investment Management LLC | 10,880 | $12.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 10,414 | $11.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 8,490 | $9.00K | 0.00% | +5,100+150.4% | Added |
| Advisor Group Holdings, Inc. | 6,179 | $6.00K | 0.00% | −428−6.5% | Reduced |
| Federated Hermes, Inc. | 5,633 | $6.00K | 0.00% | +2,427+75.7% | Added |
| Wells Fargo & Company | 2,712 | $3.00K | 0.00% | −64−2.3% | Reduced |
| Bank of America Corp | 1,196 | $1.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 476 | $1.00K | 0.00% | −32−6.3% | Reduced |
| Prospera Financial Services Inc | 504 | $1.00K | 0.00% | +504 | New |
| UBS Group AG | 1 | $0 | 0.00% | −14,631−100.0% | Reduced |
| US Bancorp | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Optimum Investment Advisors | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1 | $0 | 0.00% | 00.0% | Unchanged |
| JFS Wealth Advisors, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Focused Wealth Management, Inc | 209 | $0 | 0.00% | 00.0% | Unchanged |
| JJJ Advisors Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 21 | $0 | 0.00% | 00.0% | Unchanged |
| CVA Family Office, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1 | $0 | 0.00% | +1 | New |
| Money Concepts Capital Corp | 50 | $0 | 0.00% | +50 | New |
| Northwestern Mutual Wealth Management Co | 100 | $0 | 0.00% | +100 | New |
| Glassman Wealth Services | 1 | $0 | 0.00% | +1 | New |
| Capital Advisory Group Advisory Services, LLC | 1 | $0 | 0.00% | +1 | New |
| IFP Advisors, Inc | 2,400 | – | – | +1,200+100.0% | Added |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −98,127−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −61,246−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −52,001−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −12,444−100.0% | Sold out |
| Sigma Planning Corp | 0 | $0 | 0.00% | −10,116−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −10,087−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −1,421−100.0% | Sold out |
| Piper Sandler & Co. | 0 | $0 | 0.00% | −49,590−100.0% | Sold out |
| Harbour Investments, Inc. | – | – | – | – | Not filed |